KMICB - Immune system and malignant disease
Kent & Medway Guidance
K&M Position statement for prescribing oral methotrexate, Nov 2020 (review due June 2022)
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary